Borazan, Mehmet <br/><br/>
Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial.  [electronic resource] 

 -  Acta ophthalmologica  Aug 2009 
 - 549-54 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1755-3768 
<br/><br/><label>Standard No.: </label>10.1111/j.1755-3768.2008.01265.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Anti-Allergic Agents--administration & dosage<br/>Benzimidazoles--administration & dosage<br/>Child<br/>Conjunctival Diseases--drug therapy<br/>Conjunctivitis, Allergic--drug therapy<br/>Dibenzazepines--administration & dosage<br/>Dibenzoxepins--administration & dosage<br/>Double-Blind Method<br/>Edema--drug therapy<br/>Eyelid Diseases--drug therapy<br/>Female<br/>Fluorometholone--administration & dosage<br/>Histamine H1 Antagonists--administration & dosage<br/>Humans<br/>Imidazoles--administration & dosage<br/>Ketotifen--administration & dosage<br/>Male<br/>Middle Aged<br/>Olopatadine Hydrochloride<br/>Ophthalmic Solutions<br/>Prospective Studies<br/>Pruritus--prevention & control<br/>Seasons<br/>Tears--drug effects<br/>Treatment Outcome<br/>Young Adult